In coronary interventions, from the SCAAR registry, outcomes of NSTEMI patients pretreated with unfractionated heparin (UFH) before PCI; from the ILIAS Registry, an evaluation of the prognostic value of assessing coronary microvascular dysfunction using coronary flow reserve (CFR) and minimal microvascular resistance (MR) measurements in angina and non-obstructive coronary artery disease. A mini focus on stent thrombosis. In interventions for valvular disease: from the SOLVE-TAVI trial, a comparison of outcomes using different prosthetic valve types in TAVI for patients with left ventricular outflow tract calcification; evaluating bioprosthetic valve dysfunction after TAVI with the LOTUS, mechanically expandable transcatheter valve; and more.
Boerhout C, de Waard G, Lee JM, Mejía-Rentería H, Lee SH, Jung J, Hoshino M, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat M, Murai T, Marques K, Appelman Y, Doh J, Christiansen E, Banerjee R, Nam C, Niccoli G, Nakayama M, Tanaka N, Shin E, Beijk M, Knaapen P, Escaned J, Kakuta T, Koo B, Piek J, van de Hoef TP
Farhan S, Stachel G, Desch S, Kurz T, Feistritzer H, Hartung P, Eitel I, Nef H, Doerr O, Lauten A, Landmesser U, Sandri M, Holzhey D, Borger MA, Ince H, Öner A, Meyer-Saraei R, Wienbergen H, Fach A, Frey N, de Waha-Thiele S, Thiele H